- Report
- July 2024
- 288 Pages
Global
From €5389EUR$5,885USD£4,350GBP
- Report
- April 2025
- 50 Pages
Global
From €2512EUR$2,650USD£2,098GBP
- Report
- April 2025
- 50 Pages
Global
From €2512EUR$2,650USD£2,098GBP
Nelfinavir is a type of immune disorder drug used to treat HIV infection. It is a protease inhibitor, meaning it blocks the action of protease enzymes, which are essential for the replication of HIV. Nelfinavir is usually taken in combination with other antiretroviral drugs to reduce the amount of HIV in the body and prevent the development of drug resistance. It is also used to treat hepatitis C virus infection.
Nelfinavir is generally well tolerated, with the most common side effects being gastrointestinal disturbances such as nausea, vomiting, and diarrhea. It is important to note that nelfinavir can interact with other medications, so it is important to discuss all medications with a healthcare provider before taking nelfinavir.
Nelfinavir is available in both generic and brand-name formulations. It is typically prescribed as a tablet or capsule, and is available in both immediate-release and extended-release formulations.
Some companies in the nelfinavir market include Merck, Bristol-Myers Squibb, and Pfizer. Show Less Read more